IRadimed Corp
NASDAQ:IRMD
Net Margin
IRadimed Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
IRadimed Corp
NASDAQ:IRMD
|
934m USD |
27%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228.7B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
168.9B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
156.7B USD |
14%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
150.2B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
118B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.9B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
56B USD |
8%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.4B USD |
24%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD |
73%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
299.8B CNY |
31%
|
IRadimed Corp
Glance View
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on IRadimed Corp's most recent financial statements, the company has Net Margin of 26.6%.
You don't have any saved screeners yet